Retraction Note to: Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study (Cell and Tissue Research, (2014), 356, 2, (381-390), 10.1007/s00441-014-1797-9);Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: An in vitro study

Cell and Tissue Research

Volumn 356, Issue 2, 2014, Pages 381-390

  Jin, Pan ^a   Wu, Huayu ^a   Xu, Guojie ^a   Zheng, Li ^a   Zhao, Jinmin ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Epigallocatechin 3 gallate; Green tea; Human bone marrow; Mesenchymal stem cells; Osteogenic inducer; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE SIALOPROTEIN; COLLAGEN TYPE 1; EPIGALLOCATECHIN GALLATE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2; ANTIOXIDANT; BMP2 PROTEIN, HUMAN; CATECHIN; RUNX2 PROTEIN, HUMAN; TEA; UROKINASE;

ALP GENE; ARTICLE; BMP 2 GENE; BONE MINERALIZATION; BSP GENE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; COL I GENE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; OCN GENE; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; RUNX2 GENE; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BIOLOGICAL THERAPY; BIOSYNTHESIS; BONE DEVELOPMENT; BONE MARROW CELL; CELL LINEAGE; CYTOLOGY; DRUG EFFECTS; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; TEA;

ALKALINE PHOSPHATASE; ANTIOXIDANTS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN 2; CATECHIN; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; OSTEOPOROSIS; TEA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84902267056     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-020-03370-y     Document Type: Erratum

References (46)

1. Aubin JE (1998) Advances in the osteoblast lineage. Biochem Cell Biol 76:899-910
2. Aubin JE (2001) Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2:81-94
3. Benisch P, Schilling T, Klein-Hitpass L, Frey SP, Seefried L, Raaijmakers N, Krug M, Regensburger M, Zeck S, Schinke T (2012) The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors. PLoS One 7:e45142
4. Caplan AI (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213: 341- 347
5. Chen CH, Ho ML, Chang JK, Hung SH, Wang GJ (2005) Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos Int 16:2039-2045 (Pubitemid 41790925)
6. Chen Z, Pettinger MB, Ritenbaugh C, LaCroix AZ, Robbins J, Caan BJ, Barad DH, Hakim IA (2003) Habitual tea consumption and risk of osteoporosis: a prospective study in the women's health initiative observational cohort. Am J Epidemiol 158:772-781 (Pubitemid 37237241)
7. Cobb J, Dierich A, Huss-Garcia Y, Duboule D (2006) A mouse model for human short-stature syndromes identifies Shox2 as an upstream regulator of Runx2 during long-bone development. Proc Natl Acad Sci USA 103:4511-4515
8. Devine A, Hodgson JM, Dick IM, Prince RL (2007) Tea drinking is associated with benefits on bone density in older women. Am J Clin Nutr 86:1243-1247 (Pubitemid 47538334)
9. Fehrer C, Lepperdinger G (2005) Mesenchymal stem cell aging. Exp Gerontol 40:926-930 (Pubitemid 41682392)
10. Gangji V, Hauzeur J-P, Matos C, De Maertelaer V, Toungouz M, Lambermont M (2004) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells: a pilot study. J Bone Joint Surg Am 86:1153-1160 (Pubitemid 38724877)
11. Han D-W, Lee MH, Kim B, Lee JJ, Hyon S-H, Park J-C (2012) Preventive effects of epigallocatechin-3-O-gallate against replicative senescence associated with p53 acetylation in human dermal fibroblasts. Oxid Med Cell Longev 2012:850684
12. Hanai J-i, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo W-H, Imamura T, Ishidou Y, Fukuchi M, Shi M-J (1999) Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem 274:31577-31582
13. Harborne JB, Williams CA (2000) Advances in flavonoid research since 1992. Phytochemistry 55:481-504
14. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney J, Mundy GR (1994) Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9:855-863
15. Hegarty VM, May HM, Khaw K-T (2000) Tea drinking and bonemineral density in older women. Am J Clin Nutr 71:1003-1007 (Pubitemid 30176586)
16. Hogan BL (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594
17. Hoover PA, Webber CE, Beaumont LF, Blake JM (1996) Postmenopausal bone mineral density: relationship to calcium intake, calcium absorption, residual estrogen, body composition, and physical activity. Can J Physiol Pharmacol 74:911-917 (Pubitemid 27019776)
18. Javed A, Barnes GL, Jasanya BO, Stein JL, Gerstenfeld L, Lian JB, Stein GS (2001) Runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins. Mol Cell Biol 21:2891-2905 (Pubitemid 32244932)
19. Johnell O, Gullberg B, Kanis JA, Allander E, Elffors L, Dequeker J, Dilsen G, Gennari C, Vaz LA, Lyritis G (1995) Risk factors for hip fracture in European women: the MEDOS study. J Bone Miner Res 10:1802-1815
20. Juffroy O, Noël D, Delanoye A, Viltart O, Wolowczuk I, Verwaerde C (2009) Subcutaneous graft of D1 mouse mesenchymal stem cells leads to the formation of a bone-like structure. Differentiation 78: 223-231
21. Kamon M, Zhao R, Sakamoto K (2010) Green tea polyphenol (-)- epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells. Cell Biol Int 34:109-116
22. Kanis J, Johnell O, Gullberg B, Allander E, Elffors L, Ranstam J, Dequeker J, Dilsen G, Gennari CLVA, Vaz AL (1999) Risk factors for hip fracture in men from southern Europe: the MEDOS study. Osteoporosis Int 9:45-54 (Pubitemid 29086164)
23. Kastrinaki M-C, Andreakou I, Charbord P, Papadaki HA (2008) Isolation of human bone marrow mesenchymal stem cells using different membrane markers: comparison of colony/cloning efficiency, differentiation potential, and molecular profile. Tissue Eng Part C Methods 14:333-339
24. Lee SH, Kim B-J, Choi HJ, Cho SW, Shin CS, Park S-Y, Lee Y-S, Lee SY, Kim H-H, Kim GS (2012) (-)-Epigallocathechin-3-gallate, an AMPK activator, decreases ovariectomy-induced bone loss by suppression of bone resorption. Calcif Tissue Int 90:404-410
25. Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamaguchi A, Komori T (2001) Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 155:157-166 (Pubitemid 34286216)
26. Mauney JR, Volloch V, Kaplan DL (2005) Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11:787-802 (Pubitemid 40960782)
27. Muraki S, Yamamoto S, Ishibashi H, Oka H, Yoshimura N, Kawaguchi H, Nakamura K (2007) Diet and lifestyle associated with increased bone mineral density: cross-sectional study of Japanese elderly women at an osteoporosis outpatient clinic. J Orthop Sci 12:317-320 (Pubitemid 47174855)
28. Na K, Sun BK, Woo DG, Yang HN, Chung HM, Park KH (2007) Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2). Biomaterials 28: 2631-2637 (Pubitemid 46389528)
29. Nakagawa H, Wachi M, Woo J-T, Kato M, Kasai S, Takahashi F, Lee I-S, Nagai K (2002) Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun 292:94-101 (Pubitemid 34687334)
30. Nishimura R, Hata K, Harris SE, Ikeda F, Yoneda T (2002) Corebinding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 31:303-312 (Pubitemid 34814965)
31. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147 (Pubitemid 29282067)
32. Reddi AH (1994) Bone and cartilage differentiation. Curr Opin Genet Dev 4:737-744
33. Rodriguez R, Kondo H, Nyan M, Hao J, Miyahara T, Ohya K, Kasugai S (2011) Implantation of green tea catechin α-tricalcium phosphate combination enhances bone repair in rat skull defects. J Biomed Mater Res B Appl Biomater 98:263-271
34. Schroeder TM, Jensen ED, Westendorf JJ (2005) Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today 75:213-225 (Pubitemid 41456323)
35. Sugisawa A, Umegaki K (2002) Physiological concentrations of (-)- epigallocatechin-3-O-gallate (EGCg) prevent chromosomal damage induced by reactive oxygen species in WIL2-NS cells. J Nutr 132: 1836-1839 (Pubitemid 34742865)
36. Tielens S, Wymeersch F, Declercq H, Cornelissen M (2008) Effect of 17β-estradiol on the in vitro differentiation of murine embryonic stem cells into the osteogenic lineage. In Vitro Cell Dev Biol Anim 44:368-378
37. Vacanti V, Kong E, Suzuki G, Sato K, Canty JM, Lee T (2005) Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol 205: 194-201 (Pubitemid 41428901)
38. Vali B, Rao LG, El-Sohemy A (2007) Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells. J Nutr Biochem 18:341-347 (Pubitemid 46613954)
39. Wozney JM (1992) The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32:160-167
40. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534 (Pubitemid 19023695)
41. Wu CH, Yang YC, Yao WJ, Lu FH, Wu JS, Chang CJ (2002) Epidemiological evidence of increased bone mineral density in habitual tea drinkers. Arch Intern Med 162:1001-1006 (Pubitemid 34492528)
42. Yagi H, Tan J, Tuan RS (2013) Polyphenols suppress hydrogen peroxide-induced oxidative stress in human bone-marrow derived mesenchymal stem cells. J Cell Biochem 114:1163-1173
43. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S (1991) Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681-687 (Pubitemid 21926024)
44. Yang CH, Lin CY, Yang JH, Liou SY, Li PC, Chien CT (2009) Supplementary catechins attenuate cooking-oil-fumes-induced oxidative stress in rat lung. Chin J Physiol 52:151-159
45. Yun JH, Pang EK, Kim CS, Yoo YJ, Cho KS, Chai JK, Kim CK, Choi SH (2004) Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts. J Periodontal Res 39:300-307
46. Zur Nieden NI, Kempka G, Ahr HJ (2003) In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 71:18-27 (Pubitemid 38230416)